174 related articles for article (PubMed ID: 18355439)
1. Role of Akt isoforms in HGF-induced invasive growth of human salivary gland cancer cells.
Hara S; Nakashiro K; Goda H; Hamakawa H
Biochem Biophys Res Commun; 2008 May; 370(1):123-8. PubMed ID: 18355439
[TBL] [Abstract][Full Text] [Related]
2. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
3. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
4. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.
Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH
Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870
[TBL] [Abstract][Full Text] [Related]
6. CD151 regulates HGF-stimulated morphogenesis of human breast cancer cells.
Klosek SK; Nakashiro K; Hara S; Goda H; Hasegawa H; Hamakawa H
Biochem Biophys Res Commun; 2009 Feb; 379(4):1097-100. PubMed ID: 19159612
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
Matsushita A; Götze T; Korc M
Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivo.
Sasaki T; Nakashiro K; Tanaka H; Azuma K; Goda H; Hara S; Onodera J; Fujimoto I; Tanji N; Yokoyama M; Hamakawa H
Biochem Biophys Res Commun; 2010 Aug; 399(1):79-83. PubMed ID: 20638364
[TBL] [Abstract][Full Text] [Related]
9. CD151 forms a functional complex with c-Met in human salivary gland cancer cells.
Klosek SK; Nakashiro K; Hara S; Shintani S; Hasegawa H; Hamakawa H
Biochem Biophys Res Commun; 2005 Oct; 336(2):408-16. PubMed ID: 16139245
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells.
Kanayama S; Yamada Y; Kawaguchi R; Tsuji Y; Haruta S; Kobayashi H
Oncol Rep; 2008 Jan; 19(1):117-22. PubMed ID: 18097584
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
[TBL] [Abstract][Full Text] [Related]
12. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S
Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525
[TBL] [Abstract][Full Text] [Related]
13. Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells.
Hung CM; Kuo DH; Chou CH; Su YC; Ho CT; Way TD
J Agric Food Chem; 2011 Sep; 59(17):9683-90. PubMed ID: 21806057
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor and c-Met immunoreactivity are associated with metastasis in high grade salivary gland carcinoma.
Tsukinoki K; Yasuda M; Mori Y; Asano S; Naito H; Ota Y; Osamura RY; Watanabe Y
Oncol Rep; 2004 Nov; 12(5):1017-21. PubMed ID: 15492787
[TBL] [Abstract][Full Text] [Related]
15. The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness.
Hecht M; Schulte JH; Eggert A; Wilting J; Schweigerer L
Carcinogenesis; 2005 Dec; 26(12):2105-15. PubMed ID: 16051641
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor prevents advanced glycation end products-induced injury and oxidative stress through a PI3K/Akt-dependent pathway in human endothelial cells.
Zhou YJ; Yang HW; Wang XG; Zhang H
Life Sci; 2009 Nov; 85(19-20):670-7. PubMed ID: 19778541
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the met receptor in mesothelioma.
Mukohara T; Civiello G; Davis IJ; Taffaro ML; Christensen J; Fisher DE; Johnson BE; Jänne PA
Clin Cancer Res; 2005 Nov; 11(22):8122-30. PubMed ID: 16299245
[TBL] [Abstract][Full Text] [Related]
18. CREB is a regulatory target for the protein kinase Akt/PKB in the differentiation of pancreatic ductal cells into islet β-cells mediated by hepatocyte growth factor.
Li XY; Zhan XR; Liu XM; Wang XC
Biochem Biophys Res Commun; 2011 Jan; 404(2):711-6. PubMed ID: 21156158
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
20. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
Xu H; Washington S; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]